Alector started at buy at BofA Securities

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Alector Inc.

Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer’s disease, and Parkinson’s disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply